BRIEF-Cyclacel Pharmaceuticals reports Q1 loss per share $0.09
May 11, 2016 at 16:34 PM EDT
* Cyclacel Pharmaceuticals Inc says estimates that it has capital resources to reach beyond final analysis of seamless and continue existing programs through end of 2017